2013
DOI: 10.3390/nu5104250
|View full text |Cite
|
Sign up to set email alerts
|

The Gluten-Free Diet: Testing Alternative Cereals Tolerated by Celiac Patients

Abstract: A strict gluten-free diet (GFD) is the only currently available therapeutic treatment for patients with celiac disease, an autoimmune disorder of the small intestine associated with a permanent intolerance to gluten proteins. The complete elimination of gluten proteins contained in cereals from the diet is the key to celiac disease management. However, this generates numerous social and economic repercussions due to the ubiquity of gluten in foods. The research presented in this review focuses on the current s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
46
0
6

Year Published

2015
2015
2021
2021

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 85 publications
(59 citation statements)
references
References 78 publications
(113 reference statements)
1
46
0
6
Order By: Relevance
“…Our study showed that both cultivars do not display in vitro activities related to CD pathogenesis . Other in vitro studies have shown that the immunogenicity of oats varies depending on the cultivar used . Recently, long‐term cohort studies as well as short‐term intervention studies have revealed that oats consumption by CD patients is safe, provided that the products are uncontaminated with wheat, barley, or rye .…”
Section: New Dietary Opportunity For Ncgs Patientsmentioning
confidence: 99%
“…Our study showed that both cultivars do not display in vitro activities related to CD pathogenesis . Other in vitro studies have shown that the immunogenicity of oats varies depending on the cultivar used . Recently, long‐term cohort studies as well as short‐term intervention studies have revealed that oats consumption by CD patients is safe, provided that the products are uncontaminated with wheat, barley, or rye .…”
Section: New Dietary Opportunity For Ncgs Patientsmentioning
confidence: 99%
“…In fact, it was suggested that PREP may be released from the cells (Ahmed et al, ), even though it lacks a secretion signal and it does not contain a transmembrane region, or a lipid anchor sequence (Venäläinen et al, ). PREP has been implicated in several biological processes, including cognitive disorders (Rossner et al, ; Hannula et al, ), celiac disease (Siegel et al, ; Comino et al, ), cell death (Bär et al, ; Matsuda et al, ), learning and memory (Irazusta et al, ; D'Agostino et al, ), cell proliferation and differentiation (Matsubara et al, ; Suzuki et al, ), and glucose metabolism (Kim et al, ). However, its physiological role remains to be elucidated.…”
mentioning
confidence: 99%
“…Despite its common cytosolic localization and the lacks of a secretion signal or a lipid anchor sequence (Venäläinen et al, 2004), it is believed that PREP may be released from the cells and act outside by inactivating extracellular neuropeptides (Ahmed et al, 2005). PREP has been implicated in several biological processes, including cell proliferation and differentiation (Matsubara et al, 1998; Suzuki et al, 2014), cell death (Bär et al, 2006; Matsuda et al, 2013), glucose metabolism (Kim et al, 2014), celiac disease (Siegel et al, 2006; Comino et al, 2013), learning and memory (Irazusta et al, 2002; D’Agostino et al, 2013) and cognitive disorders (Rossner et al, 2005; Hannula et al, 2013). Further reports about the intracellular activity of PREP suggested an additional physiological role for this enzyme (Schulz et al, 2005).…”
Section: Introductionmentioning
confidence: 99%